Skip to content

13F-HR filed by Krensavage Asset Management, LLC

Krensavage Asset Management, LLC filed this 13F-HR for the quarter ended 2015-09-30, filed 2015-11-13, with 23 holding rows worth $276,257,000.

Accession
0001609251-15-000006
Filed
2015-11-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2015

A holdings report, 23 entries on the cover page, a total value of $276,257,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $276,257,000 with VALUE read as thousands by filing date, 13F file number 028-16807. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ENANTA PHARMACEUTICALS INC29251M106COM730,308$26,393,000thousands by filing date
UNITED THERAPEUTICS CORP DEL COM91307C102Stock199,573$26,192,000thousands by filing date
BAXALTA INC07177M103COM721,800$22,744,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR373,062$21,063,000thousands by filing date
ORTHOFIX INTL N VN6748L102COM610,247$20,596,000thousands by filing date
IMPAX LABORATORIES INC45256B101COM530,875$18,695,000thousands by filing date
INDIVIOR PLC ORDG4766E108Common Stock4,459,944$15,286,000thousands by filing date
HALYARD HEALTH INC40650V100COM535,943$15,242,000thousands by filing date
AMGEN INC.31162100 COM103,536$14,321,000thousands by filing dateThe CUSIP as filed is malformed.
CONMED CORP COM207410101Stock274,528$13,106,000thousands by filing date
Merck & Co.,Inc.58933Y105COM249,503$12,323,000thousands by filing date
HILL ROM HLDGS INC431475102COM205,713$10,695,000thousands by filing date
SUCAMPO PHARMACEUTICALS-CL A864909106CL A528,175$10,495,000thousands by filing date
RTI BIOLOGICS INC74975N105COM1,828,672$10,387,000thousands by filing date
DEPOMED INC249908104COM375,387$7,076,000thousands by filing date
ALLERGAN PLCG0177J108SHS24,240$6,589,000thousands by filing date
SPECTRUM PHARMACEUTICALS INC84763A108COM1,078,502$6,449,000thousands by filing date
INVACARE CORP461203101COMMON STOCK402,382$5,822,000thousands by filing date
BIOTA HOLDINGS LTD90694100 COM2,570,577$5,090,000thousands by filing dateThe CUSIP as filed is malformed.
JUNIPER PHARMACEUTICALS INC COM48203L107Stock279,717$3,295,000thousands by filing date
DIGIRAD CORP253827109COM457,699$1,712,000thousands by filing date
FURIEX PHARMACEUTICALS36106P101COM145,544$1,422,000thousands by filing date
THERAVANCE INC88338T104COMMON STOCK176,108$1,264,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001609251-15-000006this filing2015-11-13acceptance time not in the bulk data set